Skip to content

Clinical trials

Phase 2 Immunologic Deficiency Syndromes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunologic Deficiency Syndromes Phase: Phase 2 Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20042
20051
20063
20071
20081
20093
20101
20112
20132
20161
20171
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated6
Active, not recruiting5
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
Children's Hospital of Philadelphia4
National Institute of Allergy and Infectious Diseases (NIAID)4
Fred Hutchinson Cancer Center2
Columbia University1
Grifols Therapeutics LLC1
Masonic Cancer Center, University of Minnesota1
Myrexis Inc.1
New York Medical College1
Pierre Fabre Medicament1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunologic Deficiency Syndromes27
Bone Marrow Failure Disorders4
Lymphoproliferative Disorders4
Granulomatous Disease, Chronic3
Infections3
Lymphoma3
Myelodysplastic Syndromes3
Anemia, Aplastic2
Anemia, Refractory, with Excess of Blasts2
Anemia, Sickle Cell2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.